These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 9282114)
1. Multiple pathways for the regulation of telomerase activity. Holt SE; Wright WE; Shay JW Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114 [TBL] [Abstract][Full Text] [Related]
2. Multiple pathways to cellular senescence: role of telomerase repressors. Oshimura M; Barrett JC Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109 [TBL] [Abstract][Full Text] [Related]
3. Telomeres, telomerase and cancer: is the magic bullet real? Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of telomerase in cancer. Kim NW Eur J Cancer; 1997 Apr; 33(5):781-6. PubMed ID: 9282117 [TBL] [Abstract][Full Text] [Related]
5. [Telomere and telomerase in human cancer]. Hiyama K; Hiyama E; Ishioka S; Yamakido M Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230 [TBL] [Abstract][Full Text] [Related]
6. Telomerase, checkpoints and cancer. Harley CB; Sherwood SW Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104 [TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of telomerase activity and telomere length. Hathcock KS; Jeffrey Chiang Y; Hodes RJ Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
9. Analysis of telomerase activity and telomere function in cancer. Gordon KE; Parkinson EK Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541 [TBL] [Abstract][Full Text] [Related]
10. The implications of telomerase biochemistry for human disease. Morin GB Eur J Cancer; 1997 Apr; 33(5):750-60. PubMed ID: 9282113 [TBL] [Abstract][Full Text] [Related]
11. Use of telomerase to create bioengineered tissues. Shay JW; Wright WE Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914 [TBL] [Abstract][Full Text] [Related]
12. [Telomeres, telomerase and development of cancer]. Andersen TI Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791 [TBL] [Abstract][Full Text] [Related]
13. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Healy KC Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645 [TBL] [Abstract][Full Text] [Related]
14. Telomere reduction and telomerase inactivation during neuronal cell differentiation. Kruk PA; Balajee AS; Rao KS; Bohr VA Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416 [TBL] [Abstract][Full Text] [Related]
15. Role of telomerase in cellular proliferation and cancer. Holt SE; Shay JW J Cell Physiol; 1999 Jul; 180(1):10-8. PubMed ID: 10362013 [TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in patients with chronic myeloid leukemia and lymphoma. Bitisik O; Yavuz S; Yasasever V; Dalay N Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367 [TBL] [Abstract][Full Text] [Related]
17. [Telomeres, telomerase and cancer]. Soria JC; Rixe O Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798 [TBL] [Abstract][Full Text] [Related]